Drug Information Association
38th Annual Meeting
Chicago, Illinois
June 16-20, 2002

• Barcoding Human Drugs and Biologics: A regulatory initiative, Mary Gross (Posted 7/15/2002)
• Clinical Data Quality: A regulator's perspective, Stephen E. Wilson
• Communicating Risks and Benefits Through Labeling and Leaflets, Karen Lechter (Posted 7/15/2002)
• Electronic Submissions: FDA's Perspective, Roger Goetsch (Posted 7/15/2002)
• Electronic Submissions: A medical reviewer's perspective, Armando Oliva 
• DailyMed Initiative: Joint NLM/VAH/FDA project
  Enhancing Patient Safety Through Accessible Medication Information, Randy Levin
• Implementation of the Common Technical Document, Justina A. Molzon
• Integrated Analyses and the CTD Sections Addressing Safety, Robert J. Temple
• Life Cycle Management: Reviewer perspective, Jon Clark
• Medication Guides: FDA requirements, Karen Lechter (Posted 7/15/2002)
• Risk Management Tools, Marty Himmel (Posted 7/15/2002)
• The Importance of Standards:  FDA initiatives, Randy Levin
• The "New" Office of Drug Safety, Marty Himmel (Posted 7/15/2002)

Back to Top   Back to Presentations

FDA/Center for Drug Evaluation and Research
Last Updated: July 23, 2002
Originator: OTCOM/DLIS
HTML by SJW